Keywords: levemir, demonstrates, safety, efficacy, danish, drugmaker, novo

Levemir demonstrates safety and efficacy

Article | 07 February 2007

Print This

Danish drugmaker Novo Nordisk says that the results of a trial of Levemir (insulin detemir [rDNA origin] injection) are a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in